¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö : 2024-03-30

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö : 2024-03-30
±³À°ÀÏÀÚ : 2024-03-30
±³À°Àå¼Ò : ´ëÀü¾¾Á¨ÀÇ·áÀç´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦

±³À°ÁÖÁ¦ : 2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ±Ù¿¬±¸È¸

´ã´çÀÚ : Çѹμö
¿¬¶ôó : 031-981-2764

À̸ÞÀÏ : daonics@naver.com

±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í Àü°øÀÇ ¹× ±âŸÀÇ·áÁø 2¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 09:00~09:40 Malignant Hyperthermia: A Practical Guide in Korea ÀÓº´°Ç(°í·ÁÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 09:40~10:20 Anesthesia and Environment ¿À¾Æ¿µ(¼­¿ïÀÇ´ë)

ÈÞ½Ä 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 10:20~10:35 Break ()

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 10:35~11:00 Efficacy and Safety of Sugammadex in Children À̼ö¹Î(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:00~11:25 Sugammadex in Pregnant Women and Women of Childbearing Age ÀÌÁØÈ£(ÀüºÏÀÇ´ë)

Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:25~11:35 Q&A ()

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:35~12:00 Neuromuscular Blockade and Its Reversal in Geriatric Population ¼ºÅÂÀ±(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:00~12:25 Neuromuscular Blockade and Its Reversal in Musculoskeletal Disorder ÇÑÁö¿ø(Áß¾ÓÀÇ´ë)

Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:25~12:35 Q&A ()

½Ä»ç 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:35~13:35 Lunch ()

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 13:35~14:05 Good Clinical Research Practice (GCRP) in Neuromuscular Research ±¸Ã¢ÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 14:05~14:35 Common Flaws in Neuromuscular Research Á¤±âÅÂ(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 14:35~15:05 Unmet needs in Neuromuscular Research ÀÌ»ó¼®(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:05~15:20 Q&A ()

ÈÞ½Ä 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:20~15:35 Break ()

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:35~15:50 Resistance or Tachyphylaxis to Rocuronium õº¸¸§(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:50~16:05 Analysis of characteristics of patients whose sugammadex claims were denied by the Auto Insurance Claims Review Department. Á¶¼ö¿¬(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:05~16:20 Response of adductor longus muscle during obturator nerve block under deep NMB ÇÏÀº±³(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:20~16:35 Comparison of effects of sugammadex administration timing on the success rate of neuromuscular monitoring before extubation and recovery profile in patients undergoing general anesthesia À̱Կø(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:35~16:50 Rocuronium induced anaphylaxis in robotic hysterectomy À̵¿±Ù(Ãæ³²ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö : 2024-03-30""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2024 ¿Ü°ú°è ÀÔ¿øÀü´ãÀü¹®ÀÇ ¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-03-30
´ÙÀ½±Û 2024 ÀüºÏ³»°úÀÇ»çȸ Çмú´ëȸ : 2024-03-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 70 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 53 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 43 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 43 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 39 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 21 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 42 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 30 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 26 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷